RAPP - Bathi sadurunge bunga, pajak, lan amortisasi Rapport Therapeutics Inc

Rapport Therapeutics, Inc. (RAPP) management aims to transform the therapy of epilepsy and pain syndromes through a targeted approach. Changes in EBITDA_Co reflect profit dynamics, with the metric holding around 0.00. This correlates with the implementation of automated bioanalysis systems to accelerate research, as well as a solid liquidity reserve that ensures the uninterrupted conduct of clinical trials for new neuropreparations.

RAPP Rapport Corp: Bathi sadurunge mbayar bunga, pajak, lan amortisasi ing interval 23.11.2025 - 12.11.2026

Ringkesan rincian data analitis Rapport Therapeutics (RAPP)

- rega saham lan prakiraan rega para ahli:

Kurs saham Rapport Corp|RAPP - Prakiraan konsensus analis

- statistik kapitalisasi pasar:

Nilai pasar Rapport Therapeutics|RAPP - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham Rapport Therapeutics|RAPP - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku rapportrx.com|RAPP - Aset Agregat Perusahaan

- indikator total utang lan likuiditas perusahaan:

Utang marang Modal Rapport Therapeutics, Inc.|RAPP - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Rapport Therapeutics Inc|RAPP - Utang perusahaan|Utang-utang marang nilai buku Rapport Therapeutics|RAPP - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Rapport Therapeutics|Likuiditas darurat rapportrx.com

- data bathi bisnis lan rasio investasi:

RAPP - Bathi resik perusahaan|Penghasilan resik sing dikarepake Rapport Therapeutics, Inc.|RAPP - Pangali P/E|Pangali Forward P/E rapportrx.com|RAPP - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Rapport Therapeutics|RAPP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Rapport Therapeutics|RAPP - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan rapportrx.com|RAPP - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Rapport Therapeutics, Inc.

Analisis kabeh metrik perusahaan:Rapport Therapeutics, Inc.

Produk asil prodhuksi Rapport Therapeutics Inc

Rapport Therapeutics, Inc. (RAPP) focuses on developing long-term therapeutic solutions for CNS pathologies. The EBITDA volume on GURU.Markets reflects the operating cash flow before depreciation, interest, and taxes. This metric measures the business's actual ability to act as a cash generator from its core operations. For a company with inertial demand, growth in this indicator confirms the commercialization of patents. The positive trend on this chart signals a transition toward stable profitability.

Karo sapa Rapport Therapeutics, Inc. saingan